Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mymetics Corp

+ Add to Watchlist

NKQ:GR

0.020 EUR 0.0000.00%

As of 13:22:20 ET on 03/04/2015.

Company Profile for Mymetics Corp (NKQ)

Mymetics Corporation is a biotechnology company focused on the development of human vaccines and therapies in the field of retroviral and viral autoimmune diseases. The Company is currently developing vaccine and therapeutic products based on the same new molecular mimicry strategy in the field of HIV and FIV infections.

Contact Information

Mymetics Corp

Route de la Corniche 4
Epalinges, CH-1066
Switzerland
Phone: 41-21-653-4535

Key Executives for Mymetics Corp (NKQ)

Ronald KempersPresident/CEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil